A ADVAGEN
LIVE

Serial Number

99243050

Owner

Rubicon Research Limited

Attorney

TRINA A. LONGO

Filing Date

Jun 19, 2025

Add to watchlist:

No watchlists yet
View on USPTO

A ADVAGEN Trademark

Serial Number: 99243050

A ADVAGEN is a trademark filed by Rubicon Research Limited on June 19, 2025. The trademark is classified under Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific). The application is currently pending registration.

Owner Contact Info

Rubicon Research Limited

Wagle Estate, Thane West
Maharashtra 400604 , IN

Entity Type: 11

Trademark Details

Filing Date

June 19, 2025

Registration Date

Not Registered

Goods & Services

Scientific and technological services, namely, research and design in the pharmaceutical, medical, veterinary, nutrition, dietary supplements, dietetic and medical food fields; Industrial analysis and research services in the pharmaceutical, medical, veterinary, nutrition, dietary supplements, dietetic and medical food fields.

Pharmaceuticals, medical and veterinary preparations for the treatment of Autoimmune diseases and disorders, Bone and joint diseases and disorders, Cancer, Cardiovascular diseases and disorders, Endocrine diseases and disorders, Excretory diseases and disorders, Gastro-intestinal diseases and disorders, Genetic diseases and disorders, Hematologic diseases and disorders, Infectious diseases and disorders, Kidney diseases and disorders, Lung diseases and disorders, Respiratory diseases and disorders, Metabolic diseases and disorders, Muscle diseases and disorders, Musculoskeletal diseases and disorders, Nephrology diseases and disorders, Neurodegenerative diseases and disorders, Neurological diseases and disorders, Ophthalmic diseases and disorders, Dermatological diseases and disorders, Inflammatory diseases and disorders, Immune diseases and disorders, Allergic conditions and disorders, Psychiatric diseases and disorders, Digestive diseases and disorders, Nutritional diseases and disorders, Malnutrition, Vaginal and penile diseases and disorders, Reproductive diseases and disorders, Urological conditions and disorders, Central nervous system diseases and disorders, Otic diseases and disorders, Hematological diseases and disorders, Psychotic disease and disorders, Pain conditions, Headache and migraine conditions, Arthritic conditions and disorders, Neuropathic conditions and disorders, Liver diseases and disorders, High blood pressure (hypertension), high cholesterol, heart disease, and heart failure conditions, Dehydration conditions, Acute and chronic conditions and disorders, Autoimmune disorders and conditions, Mental health conditions and disorders, Physical health conditions and disorders, Sexual health conditions and disorders, and Urinary diseases and conditions; Sanitary preparations for medical purposes; Dietetic food and substances adapted for medical and veterinary use; food for babies; Dietary supplements for humans and animals; Plasters, materials for dressings for medical purposes; Material for stopping teeth, dental wax; Disinfectants; Preparations for destroying vermin; Fungicides, herbicides

Filing History

NOTIFICATION OF NON-FINAL ACTION E-MAILED
May 29, 2026 GNRN
NON-FINAL ACTION E-MAILED
May 29, 2026 GNRT
NON-FINAL ACTION WRITTEN
May 29, 2026 CNRT
TEAS/EMAIL CORRESPONDENCE ENTERED
May 12, 2026 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
May 11, 2026 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
May 11, 2026 TROA
APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
Feb 9, 2026 XELG
APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
Feb 9, 2026 XELR
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Nov 10, 2025 GNRN
NON-FINAL ACTION E-MAILED
Nov 10, 2025 GNRT
NON-FINAL ACTION WRITTEN
Nov 10, 2025 CNRT
ASSIGNED TO EXAMINER
Nov 7, 2025 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Oct 27, 2025 NWOS
APPLICATION FILING RECEIPT MAILED
Jun 19, 2025 MAFR
NEW APPLICATION ENTERED
Jun 19, 2025 NWAP